Novartis Ag (NVS) Non-Current Debt (2009 - 2025)

Novartis Ag (NVS) has 12 years of Non-Current Debt data on file, last reported at $27.9 billion in Q4 2025.

• Quarterly Non-Current Debt rose 30.75% year-over-year to $27.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.9 billion (up 30.75% YoY) and the FY2025 annual result came in at $27.9 billion, up 30.75% from the prior year.
• Non-Current Debt grew to $27.9 billion in Q4 2025 per NVS's latest filing, from $22.5 billion in the prior quarter.
• The five-year high for Non-Current Debt was $27.9 billion in Q4 2025, with the low at $18.3 billion in Q2 2023.
• Average Non-Current Debt over 5 years is $21.8 billion, with a median of $21.8 billion recorded in 2022.
• Year-over-year, Non-Current Debt slipped 17.87% in 2023 and jumped 30.75% in 2025.
• Novartis Ag's Non-Current Debt stood at $22.9 billion in 2021, then slipped by 11.61% to $20.2 billion in 2022, then dropped by 8.93% to $18.4 billion in 2023, then gained by 15.89% to $21.4 billion in 2024, then jumped by 30.75% to $27.9 billion in 2025.
• Business Quant data shows NVS's Non-Current Debt at $27.9 billion in Q4 2025, $22.5 billion in Q2 2025, and $21.4 billion in Q4 2024.